You are being downvoted but you are entirely correct. Pricing for medications in the US, including insulin, follows an absolutely nightmarish set of rituals due

You are being downvoted but you are entirely correct. Pricing for medications in the US, including insulin, follows an absolutely nightmarish set of rituals due to the need to gain access through insurers. Eli Lilly’s financials are publicly available, their revenue per unit of insulin has largely kept pace with inflation. The skyrocketing costs of the sticker price of insulin is entirely due to the lack of a universal public insurance option in the US leading to the horrific rebate system we currently have, which largely benefits insurers and PBMs. Pharma companies come out neutral (from a revenue perspective, definitely negative from a PR perspective), and consumers, particularly those on high deductible plans or without insurance, are gutted.